ASCO Presentations Indicate Bright Future For Immunotherapy Combinations in Soft Tissue Sarcoma

Jonathan C. Trent, MD, PhD, discusses data from 2 phase 2 trials of immunotherapy in soft tissue sarcoma, as well as their clinical significance.

Related Keywords

Florida ,United States ,Miami ,University Of Miami ,Jonathanc Trent ,Breelyn Wilky ,News Network ,Sylvester Comprehensive Cancer Center ,University Of Miami Miller School Medicine ,Clinical Research ,University Of Miami Health Syste ,Miami Health ,Miami Miller School ,Sylvester Comprehensive Cancer ,Sylvester ,Disco ,Soft Tissue Sarcoma ,